Deerfield led and participated in Conventus Orthopaedics, Inc. $24 million series AA equity financing. Conventus is a device company solely focused on improving patient care through a platform technology with less invasive solutions to a broad range of challenging perarticular fractures.
Its lead product, Conventus DRS™ is approved by the FDA for the treatment of distal radius fractures which has shown to reduce surgical trauma by as much as 80% as compared to traditional treatment options. Conventus is also developing a Proximal Humerus PH fracture solution for the shoulder. The financing will support commercialization of its products and accelerate R&D for new indications.